Last Price$5.30NASDAQ Previous Close - Last Trade as of 4:00PM ET 1/21/22
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change0(0.00%)
Bid (Size)$5.20 (1)
Ask (Size)$5.80 (2)
Day Low / HighN/A - N/A
Volume758.8 K

View Biotechnology IndustryPeer Comparison as of 01/21/2022


Omeros Corp ( NASDAQ )

Price: $5.30
Change: -0.05 (0.93%)
Volume: 758.8 K
4:00PM ET 1/21/2022

22nd Century Group Inc ( NASDAQ )

Price: $2.06
Change: -0.09 (4.19%)
Volume: 2.8 M
4:00PM ET 1/21/2022

Geron Corp ( NASDAQ )

Price: $1.05
Change: -0.03 (2.78%)
Volume: 2.5 M
4:00PM ET 1/21/2022

Jounce Therapeutics Inc ( NASDAQ )

Price: $6.17
Change: +0.16 (2.66%)
Volume: 348.7 K
4:00PM ET 1/21/2022

Akebia Therapeutics Inc ( NASDAQ )

Price: $2.00
Change: -0.04 (1.96%)
Volume: 4.4 M
4:00PM ET 1/21/2022

Read more news Recent News

Omeros Confirms Submission of Briefing Package to FDA Following Narsoplimab Concerns
4:05AM ET 1/20/2022 MT Newswires

Omeros (OMER) said late Wednesday it has submitted a briefing package to the US Food and Drug Administration after the agency raised concerns about...

--Cantor Fitzgerald Adjusts Omeros' Price Target to $20 From $34, Reiterates Overweight Rating
10:28AM ET 1/18/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

Omeros Closes $1 Billion Sale of Omidria Eye Medication
10:08AM ET 12/23/2021 MT Newswires

Omeros Corp. (OMER) said Thursday it has closed the sale of Omidria eye medication to Rayner Surgical in a deal valued in excess of $1 billion. The...

Sector Update: Health Care Stocks Trailing Thursday Field Higher
4:00PM ET 12/02/2021 MT Newswires

Health care stocks were ending off Thursday's pace, with the NYSE Health Care Index rising 0.5% this afternoon while the SPDR Health Care Select Sector ETF...

View all Commentary and Analysis

Omeros: A New Year Beckons
8:12AM ET 12/06/2021 Seeking Alpha

Omeros Corporation (OMER) CEO Greg Demopulos on Q3 2021 Results - Earnings Call Transcript
9:05PM ET 11/09/2021 Seeking Alpha

Omeros: What's Left
8:59PM ET 10/14/2021 Seeking Alpha

Wall Street Breakfast: What Moved Markets
7:55AM ET 10/02/2021 Seeking Alpha

Company Profile

Business DescriptionOmeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA. View company web site for more details
AddressThe Omeros Building
Seattle, Washington 98119
Phone+1 206 676-5000
Number of Employees236
Recent SEC Filing12/30/20218-K
Chairman, President & Chief Executive OfficerGregory A. Demopulos
Chief Financial Officer, Treasurer & VPMichael A. Jacobsen
Chief Scientific Officer & Vice President-ScienceGeorge A. Gaitanaris
Chief Medical Officer & Vice PresidentJ. Steven Whitaker

Company Highlights

Price Open$5.24
Previous Close$5.35
52 Week Range$5.02 - 23.85
Market Capitalization$331.5 M
Shares Outstanding62.5 M
SectorHealth Technology
Next Earnings Announcement03/07/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$1.99
Beta vs. S&P 500N/A
Revenue$29.9 M
Net Profit Margin-136.61%
Return on Equity58.08%

Analyst Ratings as of 10/08/2021

Consensus RecommendationConsensus Icon
Powered by Factset